Advertisement
Letter| Volume 113, P215-216, March 2016

Download started.

Ok

Licensing regulations for diabetes and driving—Two sides of the same coin?

Published:January 12, 2016DOI:https://doi.org/10.1016/j.diabres.2015.12.019
      We read with interest the paper by Hassoun et al. [
      • Hassoun A.A.K.
      • Abdella N.
      • Al Arouj M.
      • Al Awadi F.
      • Al Futaisi F.
      • Al Lamki M.
      • et al.
      Driving and diabetes mellitus in the Gulf Cooperation Council countries: call for action.
      ] in the October issue of Diabetes Research and Clinical Practice, “calling for action” on driving regulation in the Gulf Cooperation Council countries. Their views are consistent with current international opinion in this important area, which carries medico-legal implications [
      • Graveling A.J.
      • Frier B.M.
      Driving and diabetes: problems, licensing restrictions and recommendations for safe driving.
      ]. The article [
      • Hassoun A.A.K.
      • Abdella N.
      • Al Arouj M.
      • Al Awadi F.
      • Al Futaisi F.
      • Al Lamki M.
      • et al.
      Driving and diabetes mellitus in the Gulf Cooperation Council countries: call for action.
      ] highlights the absence of any legislation regulating driving licensing for people with diabetes in the Gulf region, and the urgent need to introduce standards for the assessment of medical fitness to drive. Although legislation has been enacted in most European countries following the 3rd European Union (EU) Directive on Driving [

      European Parliament, Council of the European Union. Commission directive 2009/113/EC of 25 August 2009 amending directive 2006/126/EC of the European Parliament and of the Council on driving licences. Off J Eur Union 2009;L223:31–35.

      ], adoption and implementation of these regulations remains heterogeneous, with different approaches being taken by EU states. To illustrate these discrepancies we draw attention to two examples from Europe, in which a seemingly different approach in terms of implementation has both positive and negative connotations.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hassoun A.A.K.
        • Abdella N.
        • Al Arouj M.
        • Al Awadi F.
        • Al Futaisi F.
        • Al Lamki M.
        • et al.
        Driving and diabetes mellitus in the Gulf Cooperation Council countries: call for action.
        Diab Res Clin Pract. 2015; 110: 91-94
        • Graveling A.J.
        • Frier B.M.
        Driving and diabetes: problems, licensing restrictions and recommendations for safe driving.
        Clin Diab Endocrinol. 2015; : 8https://doi.org/10.1186/s40842-015-0007-3
      1. European Parliament, Council of the European Union. Commission directive 2009/113/EC of 25 August 2009 amending directive 2006/126/EC of the European Parliament and of the Council on driving licences. Off J Eur Union 2009;L223:31–35.

        • Pedersen-Bjergaard U.
        • Færch L.
        • Allingbjerg M-L.
        • Agesen R.
        • Thorsteinsson B.
        The influence of new European Union driver's license legislation on reporting of severe hypoglycemia by patients with type 1 diabetes.
        Diabetes Care. 2015; 38: 29-33
        • Brož J.
        • Brabec M.
        • Janíčková Žd’árská D.
        • Fedáková Z.
        • Pospíšilová L.
        • You J.Y.
        • et al.
        Fear of driving license withdrawal in insulin-treated diabetes mellitus patients negatively influences their decision to report severe hypoglycemic events to physicians.
        Patient Prefer Adher. 2015; 9: 1367-1370